Target intelligence / Profile preview

Ribosomal protein L24 pseudogene 7 (RPL24P7)

Target
RPL24P7
Molecular classification
Other (Pseudogene), Non-coding RNA gene
01

Overview

Ribosomal protein L24 pseudogene 7 (RPL24P7) is a processed pseudogene found in the human genome, specifically on chromosome 3[8]. It is a non-coding DNA sequence derived from the ribosomal protein L24 gene but lacks the ability to encode a functional protein due to accumulated mutations or deletions. This pseudogene has no established biological function, disease associations, or therapeutic relevance. Pseudogenes like RPL24P7 are typical in the human genome, often resulting from gene duplication or retrotransposition events, and generally do not produce functional protein products[8][7]. There are no reported interactions with drugs, no disease roles, no known biomarkers, and no safety concerns regarding RPL24P7. Its significance is limited to genomic annotation rather than functional or therapeutic utility[8][7].

Other names
RPL24 pseudogene 7RPL24P7RPL24_2_348ribosomal protein L24 pseudogene 7
02

Mechanism of action

None. No mechanism of action is available as it is not a drug target.

03

Biological functions

None established; pseudogenes generally do not have known biological functions unless otherwise specified, and no functional role is reported for RPL24P7
04

Disease associations

None established. There is no reported disease association or role for RPL24P7

Beyond the preview

Go deeper on Ribosomal protein L24 pseudogene 7 (RPL24P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L24 pseudogene 7 (RPL24P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call